Global Candidiasis Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Candidiasis Drug market size was valued at USD 1196.7 million in 2023 and is forecast to a readjusted size of USD 1638.7 million by 2030 with a CAGR of 4.6% during review period.

The standard recommended dose for most Candida infections is fluconazole at 800 mg as the loading dose, followed by fluconazole at a dose of 400 mg/d either intravenously or orally for at least 2 weeks of therapy after a demonstrated negative blood culture result or clinical signs of improvement.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Candidiasis Drug industry chain, the market status of Hospital (Oral, External Use), Retail Pharmacy (Oral, External Use), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Candidiasis Drug.

Regionally, the report analyzes the Candidiasis Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Candidiasis Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Candidiasis Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Candidiasis Drug industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Oral, External Use).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Candidiasis Drug market.

Regional Analysis: The report involves examining the Candidiasis Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Candidiasis Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Candidiasis Drug:
Company Analysis: Report covers individual Candidiasis Drug players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Candidiasis Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Retail Pharmacy).

Technology Analysis: Report covers specific technologies relevant to Candidiasis Drug. It assesses the current state, advancements, and potential future developments in Candidiasis Drug areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Candidiasis Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Candidiasis Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Oral
    External Use
    Other

Market segment by Application
    Hospital
    Retail Pharmacy
    Other

Market segment by players, this report covers
    Bayer
    Perrigo
    J & J
    Pfizer
    Bristol-Myers Squibb
    Effik
    Teva
    Sanofi
    Cisen Pharmaceutical
    Kingyork Group

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Candidiasis Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Candidiasis Drug, with revenue, gross margin and global market share of Candidiasis Drug from 2019 to 2024.
Chapter 3, the Candidiasis Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Candidiasis Drug market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Candidiasis Drug.
Chapter 13, to describe Candidiasis Drug research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Candidiasis Drug
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Candidiasis Drug by Type
        1.3.1 Overview: Global Candidiasis Drug Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Candidiasis Drug Consumption Value Market Share by Type in 2023
        1.3.3 Oral
        1.3.4 External Use
        1.3.5 Other
    1.4 Global Candidiasis Drug Market by Application
        1.4.1 Overview: Global Candidiasis Drug Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospital
        1.4.3 Retail Pharmacy
        1.4.4 Other
    1.5 Global Candidiasis Drug Market Size & Forecast
    1.6 Global Candidiasis Drug Market Size and Forecast by Region
        1.6.1 Global Candidiasis Drug Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Candidiasis Drug Market Size by Region, (2019-2030)
        1.6.3 North America Candidiasis Drug Market Size and Prospect (2019-2030)
        1.6.4 Europe Candidiasis Drug Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Candidiasis Drug Market Size and Prospect (2019-2030)
        1.6.6 South America Candidiasis Drug Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Candidiasis Drug Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Bayer
        2.1.1 Bayer Details
        2.1.2 Bayer Major Business
        2.1.3 Bayer Candidiasis Drug Product and Solutions
        2.1.4 Bayer Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Bayer Recent Developments and Future Plans
    2.2 Perrigo
        2.2.1 Perrigo Details
        2.2.2 Perrigo Major Business
        2.2.3 Perrigo Candidiasis Drug Product and Solutions
        2.2.4 Perrigo Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Perrigo Recent Developments and Future Plans
    2.3 J & J
        2.3.1 J & J Details
        2.3.2 J & J Major Business
        2.3.3 J & J Candidiasis Drug Product and Solutions
        2.3.4 J & J Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 J & J Recent Developments and Future Plans
    2.4 Pfizer
        2.4.1 Pfizer Details
        2.4.2 Pfizer Major Business
        2.4.3 Pfizer Candidiasis Drug Product and Solutions
        2.4.4 Pfizer Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Pfizer Recent Developments and Future Plans
    2.5 Bristol-Myers Squibb
        2.5.1 Bristol-Myers Squibb Details
        2.5.2 Bristol-Myers Squibb Major Business
        2.5.3 Bristol-Myers Squibb Candidiasis Drug Product and Solutions
        2.5.4 Bristol-Myers Squibb Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Bristol-Myers Squibb Recent Developments and Future Plans
    2.6 Effik
        2.6.1 Effik Details
        2.6.2 Effik Major Business
        2.6.3 Effik Candidiasis Drug Product and Solutions
        2.6.4 Effik Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Effik Recent Developments and Future Plans
    2.7 Teva
        2.7.1 Teva Details
        2.7.2 Teva Major Business
        2.7.3 Teva Candidiasis Drug Product and Solutions
        2.7.4 Teva Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Teva Recent Developments and Future Plans
    2.8 Sanofi
        2.8.1 Sanofi Details
        2.8.2 Sanofi Major Business
        2.8.3 Sanofi Candidiasis Drug Product and Solutions
        2.8.4 Sanofi Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Sanofi Recent Developments and Future Plans
    2.9 Cisen Pharmaceutical
        2.9.1 Cisen Pharmaceutical Details
        2.9.2 Cisen Pharmaceutical Major Business
        2.9.3 Cisen Pharmaceutical Candidiasis Drug Product and Solutions
        2.9.4 Cisen Pharmaceutical Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Cisen Pharmaceutical Recent Developments and Future Plans
    2.10 Kingyork Group
        2.10.1 Kingyork Group Details
        2.10.2 Kingyork Group Major Business
        2.10.3 Kingyork Group Candidiasis Drug Product and Solutions
        2.10.4 Kingyork Group Candidiasis Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Kingyork Group Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Candidiasis Drug Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Candidiasis Drug by Company Revenue
        3.2.2 Top 3 Candidiasis Drug Players Market Share in 2023
        3.2.3 Top 6 Candidiasis Drug Players Market Share in 2023
    3.3 Candidiasis Drug Market: Overall Company Footprint Analysis
        3.3.1 Candidiasis Drug Market: Region Footprint
        3.3.2 Candidiasis Drug Market: Company Product Type Footprint
        3.3.3 Candidiasis Drug Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Candidiasis Drug Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Candidiasis Drug Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Candidiasis Drug Consumption Value Market Share by Application (2019-2024)
    5.2 Global Candidiasis Drug Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Candidiasis Drug Consumption Value by Type (2019-2030)
    6.2 North America Candidiasis Drug Consumption Value by Application (2019-2030)
    6.3 North America Candidiasis Drug Market Size by Country
        6.3.1 North America Candidiasis Drug Consumption Value by Country (2019-2030)
        6.3.2 United States Candidiasis Drug Market Size and Forecast (2019-2030)
        6.3.3 Canada Candidiasis Drug Market Size and Forecast (2019-2030)
        6.3.4 Mexico Candidiasis Drug Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Candidiasis Drug Consumption Value by Type (2019-2030)
    7.2 Europe Candidiasis Drug Consumption Value by Application (2019-2030)
    7.3 Europe Candidiasis Drug Market Size by Country
        7.3.1 Europe Candidiasis Drug Consumption Value by Country (2019-2030)
        7.3.2 Germany Candidiasis Drug Market Size and Forecast (2019-2030)
        7.3.3 France Candidiasis Drug Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Candidiasis Drug Market Size and Forecast (2019-2030)
        7.3.5 Russia Candidiasis Drug Market Size and Forecast (2019-2030)
        7.3.6 Italy Candidiasis Drug Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Candidiasis Drug Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Candidiasis Drug Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Candidiasis Drug Market Size by Region
        8.3.1 Asia-Pacific Candidiasis Drug Consumption Value by Region (2019-2030)
        8.3.2 China Candidiasis Drug Market Size and Forecast (2019-2030)
        8.3.3 Japan Candidiasis Drug Market Size and Forecast (2019-2030)
        8.3.4 South Korea Candidiasis Drug Market Size and Forecast (2019-2030)
        8.3.5 India Candidiasis Drug Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Candidiasis Drug Market Size and Forecast (2019-2030)
        8.3.7 Australia Candidiasis Drug Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Candidiasis Drug Consumption Value by Type (2019-2030)
    9.2 South America Candidiasis Drug Consumption Value by Application (2019-2030)
    9.3 South America Candidiasis Drug Market Size by Country
        9.3.1 South America Candidiasis Drug Consumption Value by Country (2019-2030)
        9.3.2 Brazil Candidiasis Drug Market Size and Forecast (2019-2030)
        9.3.3 Argentina Candidiasis Drug Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Candidiasis Drug Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Candidiasis Drug Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Candidiasis Drug Market Size by Country
        10.3.1 Middle East & Africa Candidiasis Drug Consumption Value by Country (2019-2030)
        10.3.2 Turkey Candidiasis Drug Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Candidiasis Drug Market Size and Forecast (2019-2030)
        10.3.4 UAE Candidiasis Drug Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Candidiasis Drug Market Drivers
    11.2 Candidiasis Drug Market Restraints
    11.3 Candidiasis Drug Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Candidiasis Drug Industry Chain
    12.2 Candidiasis Drug Upstream Analysis
    12.3 Candidiasis Drug Midstream Analysis
    12.4 Candidiasis Drug Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Candidiasis Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Candidiasis Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Candidiasis Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Candidiasis Drug Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Bayer Company Information, Head Office, and Major Competitors
    Table 6. Bayer Major Business
    Table 7. Bayer Candidiasis Drug Product and Solutions
    Table 8. Bayer Candidiasis Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Bayer Recent Developments and Future Plans
    Table 10. Perrigo Company Information, Head Office, and Major Competitors
    Table 11. Perrigo Major Business
    Table 12. Perrigo Candidiasis Drug Product and Solutions
    Table 13. Perrigo Candidiasis Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Perrigo Recent Developments and Future Plans
    Table 15. J & J Company Information, Head Office, and Major Competitors
    Table 16. J & J Major Business
    Table 17. J & J Candidiasis Drug Product and Solutions
    Table 18. J & J Candidiasis Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. J & J Recent Developments and Future Plans
    Table 20. Pfizer Company Information, Head Office, and Major Competitors
    Table 21. Pfizer Major Business
    Table 22. Pfizer Candidiasis Drug Product and Solutions
    Table 23. Pfizer Candidiasis Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Pfizer Recent Developments and Future Plans
    Table 25. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
    Table 26. Bristol-Myers Squibb Major Business
    Table 27. Bristol-Myers Squibb Candidiasis Drug Product and Solutions
    Table 28. Bristol-Myers Squibb Candidiasis Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Bristol-Myers Squibb Recent Developments and Future Plans
    Table 30. Effik Company Information, Head Office, and Major Competitors
    Table 31. Effik Major Business
    Table 32. Effik Candidiasis Drug Product and Solutions
    Table 33. Effik Candidiasis Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Effik Recent Developments and Future Plans
    Table 35. Teva Company Information, Head Office, and Major Competitors
    Table 36. Teva Major Business
    Table 37. Teva Candidiasis Drug Product and Solutions
    Table 38. Teva Candidiasis Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Teva Recent Developments and Future Plans
    Table 40. Sanofi Company Information, Head Office, and Major Competitors
    Table 41. Sanofi Major Business
    Table 42. Sanofi Candidiasis Drug Product and Solutions
    Table 43. Sanofi Candidiasis Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Sanofi Recent Developments and Future Plans
    Table 45. Cisen Pharmaceutical Company Information, Head Office, and Major Competitors
    Table 46. Cisen Pharmaceutical Major Business
    Table 47. Cisen Pharmaceutical Candidiasis Drug Product and Solutions
    Table 48. Cisen Pharmaceutical Candidiasis Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Cisen Pharmaceutical Recent Developments and Future Plans
    Table 50. Kingyork Group Company Information, Head Office, and Major Competitors
    Table 51. Kingyork Group Major Business
    Table 52. Kingyork Group Candidiasis Drug Product and Solutions
    Table 53. Kingyork Group Candidiasis Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Kingyork Group Recent Developments and Future Plans
    Table 55. Global Candidiasis Drug Revenue (USD Million) by Players (2019-2024)
    Table 56. Global Candidiasis Drug Revenue Share by Players (2019-2024)
    Table 57. Breakdown of Candidiasis Drug by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 58. Market Position of Players in Candidiasis Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 59. Head Office of Key Candidiasis Drug Players
    Table 60. Candidiasis Drug Market: Company Product Type Footprint
    Table 61. Candidiasis Drug Market: Company Product Application Footprint
    Table 62. Candidiasis Drug New Market Entrants and Barriers to Market Entry
    Table 63. Candidiasis Drug Mergers, Acquisition, Agreements, and Collaborations
    Table 64. Global Candidiasis Drug Consumption Value (USD Million) by Type (2019-2024)
    Table 65. Global Candidiasis Drug Consumption Value Share by Type (2019-2024)
    Table 66. Global Candidiasis Drug Consumption Value Forecast by Type (2025-2030)
    Table 67. Global Candidiasis Drug Consumption Value by Application (2019-2024)
    Table 68. Global Candidiasis Drug Consumption Value Forecast by Application (2025-2030)
    Table 69. North America Candidiasis Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 70. North America Candidiasis Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 71. North America Candidiasis Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 72. North America Candidiasis Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 73. North America Candidiasis Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 74. North America Candidiasis Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 75. Europe Candidiasis Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 76. Europe Candidiasis Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 77. Europe Candidiasis Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 78. Europe Candidiasis Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 79. Europe Candidiasis Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 80. Europe Candidiasis Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 81. Asia-Pacific Candidiasis Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 82. Asia-Pacific Candidiasis Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 83. Asia-Pacific Candidiasis Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 84. Asia-Pacific Candidiasis Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 85. Asia-Pacific Candidiasis Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 86. Asia-Pacific Candidiasis Drug Consumption Value by Region (2025-2030) & (USD Million)
    Table 87. South America Candidiasis Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 88. South America Candidiasis Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 89. South America Candidiasis Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 90. South America Candidiasis Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 91. South America Candidiasis Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 92. South America Candidiasis Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 93. Middle East & Africa Candidiasis Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 94. Middle East & Africa Candidiasis Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 95. Middle East & Africa Candidiasis Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 96. Middle East & Africa Candidiasis Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 97. Middle East & Africa Candidiasis Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 98. Middle East & Africa Candidiasis Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 99. Candidiasis Drug Raw Material
    Table 100. Key Suppliers of Candidiasis Drug Raw Materials
List of Figures
    Figure 1. Candidiasis Drug Picture
    Figure 2. Global Candidiasis Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Candidiasis Drug Consumption Value Market Share by Type in 2023
    Figure 4. Oral
    Figure 5. External Use
    Figure 6. Other
    Figure 7. Global Candidiasis Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 8. Candidiasis Drug Consumption Value Market Share by Application in 2023
    Figure 9. Hospital Picture
    Figure 10. Retail Pharmacy Picture
    Figure 11. Other Picture
    Figure 12. Global Candidiasis Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 13. Global Candidiasis Drug Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 14. Global Market Candidiasis Drug Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 15. Global Candidiasis Drug Consumption Value Market Share by Region (2019-2030)
    Figure 16. Global Candidiasis Drug Consumption Value Market Share by Region in 2023
    Figure 17. North America Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 18. Europe Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 19. Asia-Pacific Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 20. South America Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 21. Middle East and Africa Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 22. Global Candidiasis Drug Revenue Share by Players in 2023
    Figure 23. Candidiasis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 24. Global Top 3 Players Candidiasis Drug Market Share in 2023
    Figure 25. Global Top 6 Players Candidiasis Drug Market Share in 2023
    Figure 26. Global Candidiasis Drug Consumption Value Share by Type (2019-2024)
    Figure 27. Global Candidiasis Drug Market Share Forecast by Type (2025-2030)
    Figure 28. Global Candidiasis Drug Consumption Value Share by Application (2019-2024)
    Figure 29. Global Candidiasis Drug Market Share Forecast by Application (2025-2030)
    Figure 30. North America Candidiasis Drug Consumption Value Market Share by Type (2019-2030)
    Figure 31. North America Candidiasis Drug Consumption Value Market Share by Application (2019-2030)
    Figure 32. North America Candidiasis Drug Consumption Value Market Share by Country (2019-2030)
    Figure 33. United States Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 34. Canada Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 35. Mexico Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 36. Europe Candidiasis Drug Consumption Value Market Share by Type (2019-2030)
    Figure 37. Europe Candidiasis Drug Consumption Value Market Share by Application (2019-2030)
    Figure 38. Europe Candidiasis Drug Consumption Value Market Share by Country (2019-2030)
    Figure 39. Germany Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 40. France Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 41. United Kingdom Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 42. Russia Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 43. Italy Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 44. Asia-Pacific Candidiasis Drug Consumption Value Market Share by Type (2019-2030)
    Figure 45. Asia-Pacific Candidiasis Drug Consumption Value Market Share by Application (2019-2030)
    Figure 46. Asia-Pacific Candidiasis Drug Consumption Value Market Share by Region (2019-2030)
    Figure 47. China Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 48. Japan Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 49. South Korea Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 50. India Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 51. Southeast Asia Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 52. Australia Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 53. South America Candidiasis Drug Consumption Value Market Share by Type (2019-2030)
    Figure 54. South America Candidiasis Drug Consumption Value Market Share by Application (2019-2030)
    Figure 55. South America Candidiasis Drug Consumption Value Market Share by Country (2019-2030)
    Figure 56. Brazil Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 57. Argentina Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 58. Middle East and Africa Candidiasis Drug Consumption Value Market Share by Type (2019-2030)
    Figure 59. Middle East and Africa Candidiasis Drug Consumption Value Market Share by Application (2019-2030)
    Figure 60. Middle East and Africa Candidiasis Drug Consumption Value Market Share by Country (2019-2030)
    Figure 61. Turkey Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 62. Saudi Arabia Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 63. UAE Candidiasis Drug Consumption Value (2019-2030) & (USD Million)
    Figure 64. Candidiasis Drug Market Drivers
    Figure 65. Candidiasis Drug Market Restraints
    Figure 66. Candidiasis Drug Market Trends
    Figure 67. Porters Five Forces Analysis
    Figure 68. Manufacturing Cost Structure Analysis of Candidiasis Drug in 2023
    Figure 69. Manufacturing Process Analysis of Candidiasis Drug
    Figure 70. Candidiasis Drug Industrial Chain
    Figure 71. Methodology
    Figure 72. Research Process and Data Source

Companies Mentioned

Bayer
Perrigo
J & J
Pfizer
Bristol-Myers Squibb
Effik
Teva
Sanofi
Cisen Pharmaceutical
Kingyork Group